Clinical Trial News and Research

RSS

UA Cancer Center researchers delve deeper into benefits and harms of selenium supplementation

Personalized medicine -- health care tailored to the individual patient -- not only involves the use of prescription medications but vitamins and supplements as well.

8 Nov 2017

Discontinuation of hormone therapy linked to increased risk of cardiac, stroke death

Hormone therapy continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted.

8 Nov 2017

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

In its latest pioneering effort to harness the power of focused ultrasound to battle disease, the University of Virginia Health System is examining the scalpel-free surgery's potential to enable the body to identify and destroy metastatic breast cancer cells.

8 Nov 2017

IUD use linked to dramatic decrease in incidence of cervical cancer

Considered a safe and highly effective contraception method, intrauterine devices (IUDs) may also be quietly offering protection against the third-most common cancer in women worldwide.

8 Nov 2017

Penn Medicine to conduct Northeast’s first clinical trial of uterine transplants

Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.

7 Nov 2017

Study assesses representation of women and minorities in clinical drug trials

A new study to assess the effects of U.S.. Food and Drug Administration (FDA) regulations and guidance, intended to encourage greater inclusion of women and minorities in clinical drug trials, has shown appropriate levels of female participation based on the estimated sex ratio of people affected by a particular disease.

7 Nov 2017

New program targets cancers affecting the liver and bile ducts

Cancers affecting the liver and bile ducts will be the target of a new program at Perlmutter Cancer Center at NYU Langone Health to provide multidisciplinary clinical care and rapidly bring important new research to the clinic.

7 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).

7 Nov 2017

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with Michael Keller, MD from Children's National Health System in Washington, DC, have been awarded $4.8 million by the California Institute for Regenerative Medicine to study the use of a new T-cell therapy to help fight active viral infections in children with severe immune deficiencies.

7 Nov 2017

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

WISDOM trial aims to identify best way to screen for breast cancer

Since her 40s, Lilly Lidot has received yearly mammograms. Her sister did not get regular checkups, so when her cancer was diagnosed it had already spread to her brain. Lilly's sister died in 2010.

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Special electric dressing can combat antibiotic resistance, biofilm infection

Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic resistance and enable healing in infected burn wounds.

6 Nov 2017

Trial indicates blood-plasma infusions for Alzheimer’s patients are safe and may be effective

Researchers from Stanford University School of Medicine have found that giving blood plasma infusions taken from young donors to people with mild-to-moderate Alzheimer’s disease is not only safe and feasible, but may improve recipients’ functional ability and capacity to perform daily tasks.

6 Nov 2017

New global trial to test whether exercise could be prescribed alongside prostate cancer treatment

Queen's University Belfast are taking part in a global trial to test whether exercise should be prescribed to treat patients with advanced prostate cancer.

3 Nov 2017

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.

3 Nov 2017

Clinical Trial News and Research

UA Cancer Center researchers delve deeper into benefits and harms of selenium supplementation

Discontinuation of hormone therapy linked to increased risk of cardiac, stroke death

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

IUD use linked to dramatic decrease in incidence of cervical cancer

Penn Medicine to conduct Northeast’s first clinical trial of uterine transplants

Study assesses representation of women and minorities in clinical drug trials

New program targets cancers affecting the liver and bile ducts

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

FDA approves first targeted cancer treatment based on basket study

WISDOM trial aims to identify best way to screen for breast cancer

FDA approves new drug Zelboraf for Erdheim-Chester disease

Special electric dressing can combat antibiotic resistance, biofilm infection

Trial indicates blood-plasma infusions for Alzheimer’s patients are safe and may be effective

New global trial to test whether exercise could be prescribed alongside prostate cancer treatment

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Commonly prescribed medications may not benefit depressed CKD patients

Caffeine consumption may prolong lives of kidney disease patients

Ground-breaking eye health study offers new hope for AMD sufferers

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer